Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
specificA diffuse large B-cell lymphoma that is resistant to treatment.
28
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)(28)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →